[1]
“Ribavirin free direct-acting antivirals in adolescents with hepatitis C and thalassemia”, J Fatima Jinnah Med Univ, vol. 12, no. 3, Feb. 2019, Accessed: Jul. 13, 2026. Available: https://www.jfjmu.com/index.php/ojs/article/view/331